SAPHO syndrome

Author: Dr Sarah Hill, Dermatology Registrar, Waikato Hospital, 2006.

What is SAPHO syndrome?

SAPHO syndrome is characterised by any combination of:

The cause is unknown.

Other skin lesions seen in SAPHO syndrome include: hidradenitis suppurativa and dissecting cellulitis of the scalp.

The skin lesions in SAPHO syndrome are characterised on skin biopsy by collections of inflammatory cells, known as neutrophilic pseudoabscesses.

Bony involvement mostly affects the breast bone (sternum), resulting in decreased mobility due to pain, tenderness and swelling. The collar bones (clavicles) are also frequently enlarged on X-ray. Bone biopsy also reveals abscesses, known as sterile osteomyelitis.

SAPHO syndrome is classified along three different spectrums.

Prevalence of CRMO is estimated at 0.04% whilst the other entities are rarer.

How is the diagnosis made?

SAPHO syndrome is suspected when a patient presents with a pustular skin disease in association with rheumatic pain.

Magnetic resonance imaging (MRI scan) shows inflammation of the bone marrow or joints at characteristic sites such as the collar bone, breast bone, pelvis, heel, and lower jaw.


SAPHO has no specific drug treatment. It can be a chronic condition but eventually self-heals.

A rheumatologist may manage the joint symptoms, often prescribing nonsteroidal anti-inflammatory drugs or sulfonamides such as sulfasalazine.

A dermatologist may use vitamin A derivatives (oral retinoids) to treat the acne (isotretinoin) and the palmoplantar pustulosis (acitretin).

Other drugs that may be used include:

Related information

Email Newsletter

Would you like to receive DermNet updates by email?

Submit your images

We're seeking high-quality photos of skin diseases.  


Skin lesion photography

Watch Dr Amanda Oakley presenting "Skin lesion photography" at The Australasian Skin Cancer Congress.

Subscribe to our mailing list

* indicates required
DermNet NZ Newsletter